Biopharmaceutical Environmental Monitoring - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511246540

Publication Date:

November 8, 2024

Pages:

108

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Environmental monitoring is a process that determines the quality of a controlled environment via microbial data collection. It is essential in the biotech and pharmaceutical production process to confirm work is performed in controlled environments based on microbial data collection and assessment. Environmental monitoring ensures that biotech or pharmaceutical products are safe, reliable and meet quality standards.
The global market for Biopharmaceutical Environmental Monitoring was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Environmental Monitoring, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biopharmaceutical Environmental Monitoring by region & country, by Type, and by Application.
The Biopharmaceutical Environmental Monitoring market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Environmental Monitoring.
麻豆原创 Segmentation
By Company
Danaher Corporation
Thermo Fisher Scientific
Merck KGaA
Eurofins Sinensis
Lonza
Biomerieux
VAI
Cosasco
Amphenol Advanced Sensors
Vaisala
RMONI
Segment by Type:
Monitoring Equipment
Media
Software
Microbiology Services
Segment by Application
Pharma Companies
Pharma Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Biopharmaceutical Environmental Monitoring manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Biopharmaceutical Environmental Monitoring in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Biopharmaceutical Environmental Monitoring in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Biopharmaceutical Environmental Monitoring Product Introduction
1.2 Global Biopharmaceutical Environmental Monitoring 麻豆原创 Size Forecast
1.3 Biopharmaceutical Environmental Monitoring 麻豆原创 Trends & Drivers
1.3.1 Biopharmaceutical Environmental Monitoring Industry Trends
1.3.2 Biopharmaceutical Environmental Monitoring 麻豆原创 Drivers & Opportunity
1.3.3 Biopharmaceutical Environmental Monitoring 麻豆原创 Challenges
1.3.4 Biopharmaceutical Environmental Monitoring 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biopharmaceutical Environmental Monitoring Players Revenue Ranking (2023)
2.2 Global Biopharmaceutical Environmental Monitoring Revenue by Company (2019-2024)
2.3 Key Companies Biopharmaceutical Environmental Monitoring Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biopharmaceutical Environmental Monitoring Product Offered
2.5 Key Companies Time to Begin Mass Production of Biopharmaceutical Environmental Monitoring
2.6 Biopharmaceutical Environmental Monitoring 麻豆原创 Competitive Analysis
2.6.1 Biopharmaceutical Environmental Monitoring 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Biopharmaceutical Environmental Monitoring Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Environmental Monitoring as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Monitoring Equipment
3.1.2 Media
3.1.3 Software
3.1.4 Microbiology Services
3.2 Global Biopharmaceutical Environmental Monitoring Sales Value by Type
3.2.1 Global Biopharmaceutical Environmental Monitoring Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Biopharmaceutical Environmental Monitoring Sales Value, by Type (2019-2030)
3.2.3 Global Biopharmaceutical Environmental Monitoring Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharma Companies
4.1.2 Pharma Laboratories
4.2 Global Biopharmaceutical Environmental Monitoring Sales Value by Application
4.2.1 Global Biopharmaceutical Environmental Monitoring Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Biopharmaceutical Environmental Monitoring Sales Value, by Application (2019-2030)
4.2.3 Global Biopharmaceutical Environmental Monitoring Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Biopharmaceutical Environmental Monitoring Sales Value by Region
5.1.1 Global Biopharmaceutical Environmental Monitoring Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Biopharmaceutical Environmental Monitoring Sales Value by Region (2019-2024)
5.1.3 Global Biopharmaceutical Environmental Monitoring Sales Value by Region (2025-2030)
5.1.4 Global Biopharmaceutical Environmental Monitoring Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Biopharmaceutical Environmental Monitoring Sales Value, 2019-2030
5.2.2 North America Biopharmaceutical Environmental Monitoring Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Biopharmaceutical Environmental Monitoring Sales Value, 2019-2030
5.3.2 Europe Biopharmaceutical Environmental Monitoring Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Biopharmaceutical Environmental Monitoring Sales Value, 2019-2030
5.4.2 Asia Pacific Biopharmaceutical Environmental Monitoring Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Biopharmaceutical Environmental Monitoring Sales Value, 2019-2030
5.5.2 South America Biopharmaceutical Environmental Monitoring Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biopharmaceutical Environmental Monitoring Sales Value, 2019-2030
5.6.2 Middle East & Africa Biopharmaceutical Environmental Monitoring Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biopharmaceutical Environmental Monitoring Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Biopharmaceutical Environmental Monitoring Sales Value
6.3 United States
6.3.1 United States Biopharmaceutical Environmental Monitoring Sales Value, 2019-2030
6.3.2 United States Biopharmaceutical Environmental Monitoring Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Biopharmaceutical Environmental Monitoring Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Biopharmaceutical Environmental Monitoring Sales Value, 2019-2030
6.4.2 Europe Biopharmaceutical Environmental Monitoring Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Biopharmaceutical Environmental Monitoring Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Biopharmaceutical Environmental Monitoring Sales Value, 2019-2030
6.5.2 China Biopharmaceutical Environmental Monitoring Sales Value by Type (%), 2023 VS 2030
6.5.3 China Biopharmaceutical Environmental Monitoring Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Biopharmaceutical Environmental Monitoring Sales Value, 2019-2030
6.6.2 Japan Biopharmaceutical Environmental Monitoring Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Biopharmaceutical Environmental Monitoring Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Biopharmaceutical Environmental Monitoring Sales Value, 2019-2030
6.7.2 South Korea Biopharmaceutical Environmental Monitoring Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Biopharmaceutical Environmental Monitoring Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Biopharmaceutical Environmental Monitoring Sales Value, 2019-2030
6.8.2 Southeast Asia Biopharmaceutical Environmental Monitoring Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Biopharmaceutical Environmental Monitoring Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Biopharmaceutical Environmental Monitoring Sales Value, 2019-2030
6.9.2 India Biopharmaceutical Environmental Monitoring Sales Value by Type (%), 2023 VS 2030
6.9.3 India Biopharmaceutical Environmental Monitoring Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Danaher Corporation
7.1.1 Danaher Corporation Profile
7.1.2 Danaher Corporation Main Business
7.1.3 Danaher Corporation Biopharmaceutical Environmental Monitoring Products, Services and Solutions
7.1.4 Danaher Corporation Biopharmaceutical Environmental Monitoring Revenue (US$ Million) & (2019-2024)
7.1.5 Danaher Corporation Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific Biopharmaceutical Environmental Monitoring Products, Services and Solutions
7.2.4 Thermo Fisher Scientific Biopharmaceutical Environmental Monitoring Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 Merck KGaA
7.3.1 Merck KGaA Profile
7.3.2 Merck KGaA Main Business
7.3.3 Merck KGaA Biopharmaceutical Environmental Monitoring Products, Services and Solutions
7.3.4 Merck KGaA Biopharmaceutical Environmental Monitoring Revenue (US$ Million) & (2019-2024)
7.3.5 Eurofins Sinensis Recent Developments
7.4 Eurofins Sinensis
7.4.1 Eurofins Sinensis Profile
7.4.2 Eurofins Sinensis Main Business
7.4.3 Eurofins Sinensis Biopharmaceutical Environmental Monitoring Products, Services and Solutions
7.4.4 Eurofins Sinensis Biopharmaceutical Environmental Monitoring Revenue (US$ Million) & (2019-2024)
7.4.5 Eurofins Sinensis Recent Developments
7.5 Lonza
7.5.1 Lonza Profile
7.5.2 Lonza Main Business
7.5.3 Lonza Biopharmaceutical Environmental Monitoring Products, Services and Solutions
7.5.4 Lonza Biopharmaceutical Environmental Monitoring Revenue (US$ Million) & (2019-2024)
7.5.5 Lonza Recent Developments
7.6 Biomerieux
7.6.1 Biomerieux Profile
7.6.2 Biomerieux Main Business
7.6.3 Biomerieux Biopharmaceutical Environmental Monitoring Products, Services and Solutions
7.6.4 Biomerieux Biopharmaceutical Environmental Monitoring Revenue (US$ Million) & (2019-2024)
7.6.5 Biomerieux Recent Developments
7.7 VAI
7.7.1 VAI Profile
7.7.2 VAI Main Business
7.7.3 VAI Biopharmaceutical Environmental Monitoring Products, Services and Solutions
7.7.4 VAI Biopharmaceutical Environmental Monitoring Revenue (US$ Million) & (2019-2024)
7.7.5 VAI Recent Developments
7.8 Cosasco
7.8.1 Cosasco Profile
7.8.2 Cosasco Main Business
7.8.3 Cosasco Biopharmaceutical Environmental Monitoring Products, Services and Solutions
7.8.4 Cosasco Biopharmaceutical Environmental Monitoring Revenue (US$ Million) & (2019-2024)
7.8.5 Cosasco Recent Developments
7.9 Amphenol Advanced Sensors
7.9.1 Amphenol Advanced Sensors Profile
7.9.2 Amphenol Advanced Sensors Main Business
7.9.3 Amphenol Advanced Sensors Biopharmaceutical Environmental Monitoring Products, Services and Solutions
7.9.4 Amphenol Advanced Sensors Biopharmaceutical Environmental Monitoring Revenue (US$ Million) & (2019-2024)
7.9.5 Amphenol Advanced Sensors Recent Developments
7.10 Vaisala
7.10.1 Vaisala Profile
7.10.2 Vaisala Main Business
7.10.3 Vaisala Biopharmaceutical Environmental Monitoring Products, Services and Solutions
7.10.4 Vaisala Biopharmaceutical Environmental Monitoring Revenue (US$ Million) & (2019-2024)
7.10.5 Vaisala Recent Developments
7.11 RMONI
7.11.1 RMONI Profile
7.11.2 RMONI Main Business
7.11.3 RMONI Biopharmaceutical Environmental Monitoring Products, Services and Solutions
7.11.4 RMONI Biopharmaceutical Environmental Monitoring Revenue (US$ Million) & (2019-2024)
7.11.5 RMONI Recent Developments
8 Industry Chain Analysis
8.1 Biopharmaceutical Environmental Monitoring Industrial Chain
8.2 Biopharmaceutical Environmental Monitoring Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biopharmaceutical Environmental Monitoring Sales Model
8.5.2 Sales Channel
8.5.3 Biopharmaceutical Environmental Monitoring Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Danaher Corporation
Thermo Fisher Scientific
Merck KGaA
Eurofins Sinensis
Lonza
Biomerieux
VAI
Cosasco
Amphenol Advanced Sensors
Vaisala
RMONI

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.